サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1802114

ウイルス検体採取の世界市場：市場規模の分析 (製品別、検体の種類別、地域別) と将来予測 (2025～2035年)

Global Virology Specimen Collection Market Size Study & Forecast, by Product by Sample Type and Regional Forecasts 2025-2035

出版日
ページ情報
英文 285 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
ウイルス検体採取の世界市場：市場規模の分析 (製品別、検体の種類別、地域別) と将来予測 (2025～2035年)
出版日: 2025年09月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 285 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場の定義と概要

世界のウイルス検体採取の市場規模は、2024年に約63億7,000万米ドルとなり、予測期間中（2025～2035年）に4.62％のCAGRで拡大すると予測されています。ウイルス検体採取は、検査室検査用の高品質な臨床サンプルを確保することで、感染症診断、サーベイランス、研究の礎を形成しています。ウイルス輸送培地、スワブ、採血キット、チューブなど様々な製品が含まれ、これらはすべて正確な検出と信頼できる疫学的結果に不可欠です。ウイルス感染症の蔓延が拡大していることに加え、公衆衛生への取り組みが拡大し、パンデミック対策への資金が増加していることが、効率的な検体収集ソリューションへの需要を煽っています。さらに、インフルエンザ、HIV、HPV、新興人獣共通感染症の負担増は、臨床および研究環境における検体採取製品の不可欠な役割を強調し続けています。

ウイルス診断検査に対する需要の高まりが、検体採取キットの普及を直接後押ししています。世界の医療システムは、COVID-19のパンデミック時に前例のない課題を経験したため、診断インフラの強化に戦略的に投資しており、標準化された信頼性の高い採取方法の重要性を強化しています。例えば、世界保健機関（WHO）は、インフルエンザやコロナウイルスなどの呼吸器系ウイルスが依然として年間罹患率の上位を占めており、強固な検査プロトコルが必要であることを強調しています。さらに、綿棒材料の技術的進歩、ウイルス輸送培地製剤の改良、検体処理における自動化の統合が、市場の成長をさらに促進しています。しかし、原材料コストの変動、規制の複雑さ、デジタルヘルスと非侵襲的検査技術への徐々にではあるが着実なシフトは、長期的には拡大ペースを弱める可能性があります。

市場の詳細なセグメントとサブセグメントは以下の通りです：

目次

第1章 世界のウイルス検体採取市場：分析範囲・手法

  • 分析目的
  • 分析手法
    • 予測モデル
    • 机上分析
    • トップダウンとボトムアップのアプローチ
  • 分析の属性
  • 分析範囲
    • 市場の定義
    • 市場区分
  • 分析前提条件
    • 包含と除外
    • 制限事項
    • 分析対象期間

第2章 エグゼクティブサマリー

  • CEO/CXOの立場
  • 戦略的洞察
  • ESG分析
  • 主な分析結果

第3章 世界のウイルス検体採取市場：力学分析

  • 世界のウイルス検体採取市場を左右する市場力学（2024～2035年）
  • 促進要因
    • 公衆衛生の取り組みとパンデミック対策のための資金増額
    • ウイルス診断検査の需要増大
  • 抑制要因
    • インフルエンザ、HIV、HPV、新興人獣共通感染症の負担の増大
    • 原材料費の変動、規制の複雑さ
    • デジタルヘルスと非侵襲的検査技術への着実な移行
  • 機会
    • 綿棒材料の技術的進歩
    • ウイルス輸送培地の配合の改良
    • 検体処理における自動化の統合が、市場成長をさらに促進

第4章 世界のウイルス検体採取産業の分析

  • ポーターのファイブフォース分析
    • 買い手の交渉力
    • サプライヤーの交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース：予測モデル（2024～2035年）
  • PESTEL分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境的
    • 法的
  • 主な投資機会
  • 主要成功戦略（2025年）
  • 市場シェア分析（2024～2025年）
  • 世界の価格分析と動向（2025年）
  • アナリストの提言と結論

第5章 世界のウイルス検体採取の市場規模・予測：製品別（2025～2035年）

  • 市場概要
  • 世界のウイルス検体採取市場の業績：潜在力分析（2025年）
  • ウイルス輸送培地
  • スワブ
  • 採血キット
  • 検体採取チューブ

第6章 世界のウイルス検体採取の市場規模・予測：検体の種類別（2025～2035年）

  • 市場概要
  • 世界のウイルス検体採取市場の業績：潜在力分析（2025年）
  • 血
  • 頸部
  • 鼻腔
  • 鼻咽頭
  • 喉
  • 口腔

第7章 世界のウイルス検体採取の市場規模・予測：地域別（2025～2035年）

  • 地域市場のスナップショット
  • 主要先進国・新興国
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国>
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア（KSA）
    • 南アフリカ

第8章 競合情報

  • 主要市場の戦略
  • Abbott Laboratories
    • 企業概要
    • 主要幹部
    • 企業のスナップショット
    • 財務実績（データの入手可能性によります）
    • 製品/サービスポートフォリオ
    • 最近の開発
    • 市場戦略
    • SWOT分析
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company（BD）
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Cardinal Health Inc.
  • Puritan Medical Products
  • Quest Diagnostics Incorporated
  • Copan Diagnostics Inc.
  • Medline Industries LP
  • Qiagen N.V.
  • Greiner Bio-One International GmbH
  • Longhorn Vaccines & Diagnostics LLC
  • Hardy Diagnostics
  • HiMedia Laboratories Pvt. Ltd.
目次

Market Definition and Overview

The Global Virology Specimen Collection Market is valued at approximately USD 6.37 billion in 2024 and is projected to expand at a CAGR of 4.62% during the forecast period 2025-2035. Virology specimen collection forms the cornerstone of infectious disease diagnosis, surveillance, and research by ensuring high-quality clinical samples for laboratory testing. It encompasses a range of products such as viral transport media, swabs, blood collection kits, and tubes, all of which are critical to accurate detection and reliable epidemiological outcomes. The growing prevalence of viral infections, coupled with expanding public health initiatives and increased funding for pandemic preparedness, has fueled demand for efficient specimen collection solutions. Moreover, the rising burden of influenza, HIV, HPV, and emerging zoonotic diseases continues to underscore the indispensable role of specimen collection products in clinical and research settings.

The escalating demand for viral diagnostic testing has directly driven the uptake of specimen collection kits. Global healthcare systems, having experienced unprecedented challenges during the COVID-19 pandemic, are strategically investing in strengthening diagnostic infrastructure, thereby reinforcing the importance of standardized and reliable collection methods. For instance, the World Health Organization highlights that respiratory viruses such as influenza and coronaviruses remain among the top causes of annual morbidity, necessitating robust testing protocols. Additionally, technological advancements in swab materials, improvements in viral transport media formulations, and the integration of automation in specimen processing are further propelling market growth. However, fluctuating costs of raw materials, regulatory complexities, and a gradual but steady shift towards digital health and non-invasive testing techniques could temper the pace of expansion over the long term.

The detailed segments and sub-segments included in the report are:

By Product:

  • Viral Transport Media
  • Swabs
  • Blood Collection Kits
  • Specimen Collection Tubes

By Sample Type:

  • Blood
  • Cervical
  • Nasal
  • Nasopharyngeal
  • Throat
  • Oral

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
  • Segment Insights
  • From a segmentation standpoint, blood samples represent one of the most widely collected categories due to their clinical relevance across multiple virology applications, including HIV, hepatitis, and emerging viral infections. Cervical samples also account for a substantial portion of the market, particularly driven by global cervical cancer screening programs linked to HPV testing. Meanwhile, nasopharyngeal and nasal samples emerged as pivotal collection types during the COVID-19 pandemic and continue to remain integral for respiratory viral diagnostics. In terms of product types, viral transport media remain the backbone of the market, as they ensure sample integrity during transport and storage, while swabs are projected to retain significant demand due to their direct role in specimen acquisition. Blood collection kits and specimen tubes are also gaining traction, especially with the expansion of population-wide surveillance programs.
  • Regional Insights
  • Regionally, North America held the dominant market position in 2025, fueled by advanced healthcare infrastructure, extensive adoption of diagnostic testing, and strong presence of leading market players. Europe follows closely, supported by large-scale virology surveillance programs and government-backed research initiatives. On the other hand, Asia Pacific is expected to emerge as the fastest-growing regional market during the forecast period, driven by rapid urbanization, large patient populations, and a rising focus on infectious disease control in nations such as China and India. Favorable government policies, growing healthcare expenditure, and increasing collaborations between global and regional diagnostic players are further solidifying the market's expansion in APAC. Meanwhile, Latin America and the Middle East & Africa are gradually ramping up their virology diagnostic capabilities, providing untapped opportunities for global stakeholders.

Major market players included in this report are:

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company (BD)
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Cardinal Health Inc.
  • Puritan Medical Products
  • Quest Diagnostics Incorporated
  • Copan Diagnostics Inc.
  • Medline Industries LP
  • Qiagen N.V.
  • Greiner Bio-One International GmbH
  • Longhorn Vaccines & Diagnostics LLC
  • Hardy Diagnostics

Global Spacer Fluid Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of the competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Virology Specimen Collection Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. key Findings

Chapter 3. Global Virology Specimen Collection Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Virology Specimen Collection Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Public health initiatives and increased funding for pandemic preparedness
    • 3.2.2. Escalating demand for viral diagnostic testing
  • 3.3. Restraints
    • 3.3.1. The rising burden of influenza, HIV, HPV, and emerging zoonotic diseases
    • 3.3.2. Fluctuating costs of raw materials, regulatory complexities
    • 3.3.3. Steady shift towards digital health and non-invasive testing techniques
  • 3.4. Opportunities
    • 3.4.1. technological advancements in swab materials
    • 3.4.2. Improvements in viral transport media formulations
    • 3.4.3. The integration of automation in specimen processing are further propelling market growth

Chapter 4. Global Virology Specimen Collection Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Virology Specimen Collection Market Size & Forecasts by Product 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 5.3. Viral Transport Media
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. Swabs
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035
  • 5.5. Blood collection Kits
    • 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.5.2. Market size analysis, by region, 2025-2035
  • 5.6. Specimen Collection Tubes
    • 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.6.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Virology Specimen Collection Market Size & Forecasts by Sample Type 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 6.3. Blood
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Cervical
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035
  • 6.5. Nasal
    • 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.5.2. Market size analysis, by region, 2025-2035
  • 6.6. Nasopharyngeal
    • 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.6.2. Market size analysis, by region, 2025-2035
  • 6.7. Throat
    • 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.7.2. Market size analysis, by region, 2025-2035
  • 6.8. Oral
    • 6.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.8.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Virology Specimen Collection Market Size & Forecasts by Region 2025-2035

  • 7.1. Growth Virology Specimen Collection Market, Regional Market Snapshot
  • 7.2. Top Leading & Emerging Countries
  • 7.3. North America Virology Specimen Collection Market
    • 7.3.1. U.S. Virology Specimen Collection Market
    • 7.3.2. Canada Virology Specimen Collection Market
  • 7.4. Europe Virology Specimen Collection Market
    • 7.4.2. Germany Virology Specimen Collection Market
    • 7.4.3. France Virology Specimen Collection Market
    • 7.4.4. Spain Virology Specimen Collection Market
    • 7.4.5. Italy Virology Specimen Collection Market
    • 7.4.6. Rest of Europe Virology Specimen Collection Market
  • 7.5. Asia Pacific Virology Specimen Collection Market
    • 7.5.1. China Virology Specimen Collection Market
    • 7.5.2. India Virology Specimen Collection Market
    • 7.5.3. Japan Virology Specimen Collection Market
    • 7.5.4. Australia Virology Specimen Collection Market
    • 7.5.5. South Korea Virology Specimen Collection Market>
    • 7.5.6. Rest of APAC Virology Specimen Collection Market
  • 7.6. Latin America Virology Specimen Collection Market
    • 7.6.1. Brazil Virology Specimen Collection Market
    • 7.6.2. Mexico Virology Specimen Collection Market
  • 7.7. Middle East and Africa Virology Specimen Collection Market
    • 7.7.1. UAE Virology Specimen Collection Market
    • 7.7.2. Saudi Arabia (KSA) Virology Specimen Collection Market
    • 7.7.3. South Africa Virology Specimen Collection Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Abbott Laboratories
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Financial Performance (Subject to Data Availability)
    • 8.2.5. Product/Services Port
    • 8.2.6. Recent Development
    • 8.2.7. Market Strategies
    • 8.2.8. SWOT Analysis
  • 8.3. Thermo Fisher Scientific Inc.
  • 8.4. Becton, Dickinson and Company (BD)
  • 8.5. Danaher Corporation
  • 8.6. F. Hoffmann-La Roche Ltd.
  • 8.7. Cardinal Health Inc.
  • 8.8. Puritan Medical Products
  • 8.9. Quest Diagnostics Incorporated
  • 8.10. Copan Diagnostics Inc.
  • 8.11. Medline Industries LP
  • 8.12. Qiagen N.V.
  • 8.13. Greiner Bio-One International GmbH
  • 8.14. Longhorn Vaccines & Diagnostics LLC
  • 8.15. Hardy Diagnostics
  • 8.16. HiMedia Laboratories Pvt. Ltd.